Jayson Bedford
Stock Analyst at Raymond James
(3.78)
# 715
Out of 5,012 analysts
318
Total ratings
54.15%
Success rate
7.07%
Average return
Main Sectors:
Stocks Rated by Jayson Bedford
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZBH Zimmer Biomet Holdings | Maintains: Outperform | $104 → $113 | $99.06 | +14.07% | 9 | Aug 8, 2025 | |
| ICUI ICU Medical | Maintains: Strong Buy | $187 → $180 | $118.10 | +52.41% | 21 | Aug 8, 2025 | |
| MMSI Merit Medical Systems | Maintains: Outperform | $108 → $102 | $82.70 | +23.34% | 28 | Jul 31, 2025 | |
| DXCM DexCom | Maintains: Strong Buy | $99 → $102 | $66.03 | +54.48% | 31 | Jul 31, 2025 | |
| BSX Boston Scientific | Maintains: Strong Buy | $121 → $124 | $95.90 | +29.30% | 26 | Jul 24, 2025 | |
| ABT Abbott Laboratories | Maintains: Outperform | $142 → $141 | $133.02 | +6.00% | 29 | Jul 18, 2025 | |
| PODD Insulet | Maintains: Outperform | $328 → $360 | $313.45 | +14.85% | 27 | May 27, 2025 | |
| MASI Masimo | Maintains: Outperform | $204 → $185 | $150.25 | +23.13% | 7 | May 7, 2025 | |
| JNJ Johnson & Johnson | Maintains: Outperform | $162 → $164 | $188.89 | -13.18% | 23 | Apr 16, 2025 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $560 → $688 | $440.94 | +56.03% | 8 | Jan 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $275 → $270 | $192.53 | +40.24% | 3 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $13 | $16.90 | -23.08% | 1 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $12 → $10 | $11.05 | -9.50% | 14 | Jan 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $227 → $271 | $126.89 | +113.57% | 12 | Dec 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $15.37 | - | 10 | Nov 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $14.52 | - | 13 | Apr 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $76.72 | - | 20 | Feb 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $22.90 | - | 6 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $98.33 | - | 14 | Aug 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $0.47 | - | 4 | Mar 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $75 → $86 | $67.73 | +26.97% | 4 | Nov 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $1.76 | - | 5 | Aug 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $14.43 | - | 3 | Jan 2, 2018 |
Zimmer Biomet Holdings
Aug 8, 2025
Maintains: Outperform
Price Target: $104 → $113
Current: $99.06
Upside: +14.07%
ICU Medical
Aug 8, 2025
Maintains: Strong Buy
Price Target: $187 → $180
Current: $118.10
Upside: +52.41%
Merit Medical Systems
Jul 31, 2025
Maintains: Outperform
Price Target: $108 → $102
Current: $82.70
Upside: +23.34%
DexCom
Jul 31, 2025
Maintains: Strong Buy
Price Target: $99 → $102
Current: $66.03
Upside: +54.48%
Boston Scientific
Jul 24, 2025
Maintains: Strong Buy
Price Target: $121 → $124
Current: $95.90
Upside: +29.30%
Abbott Laboratories
Jul 18, 2025
Maintains: Outperform
Price Target: $142 → $141
Current: $133.02
Upside: +6.00%
Insulet
May 27, 2025
Maintains: Outperform
Price Target: $328 → $360
Current: $313.45
Upside: +14.85%
Masimo
May 7, 2025
Maintains: Outperform
Price Target: $204 → $185
Current: $150.25
Upside: +23.13%
Johnson & Johnson
Apr 16, 2025
Maintains: Outperform
Price Target: $162 → $164
Current: $188.89
Upside: -13.18%
Intuitive Surgical
Jan 24, 2025
Maintains: Outperform
Price Target: $560 → $688
Current: $440.94
Upside: +56.03%
Aug 2, 2024
Maintains: Outperform
Price Target: $275 → $270
Current: $192.53
Upside: +40.24%
Jul 1, 2024
Initiates: Outperform
Price Target: $13
Current: $16.90
Upside: -23.08%
Jan 9, 2024
Maintains: Outperform
Price Target: $12 → $10
Current: $11.05
Upside: -9.50%
Dec 20, 2023
Maintains: Outperform
Price Target: $227 → $271
Current: $126.89
Upside: +113.57%
Nov 16, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $15.37
Upside: -
Apr 24, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $14.52
Upside: -
Feb 6, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $76.72
Upside: -
Jan 5, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $22.90
Upside: -
Aug 24, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $98.33
Upside: -
Mar 5, 2021
Downgrades: Underperform
Price Target: n/a
Current: $0.47
Upside: -
Nov 5, 2020
Maintains: Outperform
Price Target: $75 → $86
Current: $67.73
Upside: +26.97%
Aug 2, 2019
Downgrades: Market Perform
Price Target: n/a
Current: $1.76
Upside: -
Jan 2, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $14.43
Upside: -